|
Volumn 25, Issue 1, 2008, Pages 1-30
|
NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISICKLING AGENT;
HYDROXYUREA;
ADOLESCENT;
ADULT;
CHILD;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
FEMALE;
HUMAN;
INFANT;
MALE;
MEDICAL RESEARCH;
PRESCHOOL CHILD;
SICKLE CELL ANEMIA;
ADOLESCENT;
ADULT;
ANEMIA, SICKLE CELL;
ANTISICKLING AGENTS;
BIOMEDICAL RESEARCH;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
HYDROXYUREA;
INFANT;
MALE;
|
EID: 48549084388
PISSN: None
EISSN: 15530779
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (23)
|
References (0)
|